Ashwini Kurshan

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Ashwini Kurshan, Luke B Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores
Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals. Oxford open immunology 4 (1) (2023)
Ashwini Kurshan, Luke B Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores
Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals. Oxford open immunology 4 (1) (2023)
Patrick Harrington, Ashwini Kurshan, Marc Delord, Thomas Lechmere, Amna Sheikh, Jamie Saunders, Chandan Saha, Richard Dillon, Claire Woodley, Susan Asirvatham, Natalia Curto-Garcia, Jennifer O'Sullivan, Shahram Kordasti, Deepti H Radia, Donal P McLornan, Michael H Malim, Claire N Harrison, Katie J Doores, Hugues de Lavallade
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders. Blood advances (2022)
Carl Graham, Thomas Lechmere, Aisha Rehman, Jeffrey Seow, Ashwini Kurshan, Isabella Huettner, Thomas J A Maguire, Jerry C H Tam, Daniel Cox, Christopher Ward, Mariusz Racz, Anele Waters, Christine Mant, Michael H Malim, Julie Fox, Katie J Doores
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern. PLoS pathogens 18 (10) (2022)

Ashwini Kurshan.css-eqlu8i{font-size:small;padding-left:4px;}